Metabolic injury-induced NLRP3 inflammasome activation dampens phospholipid degradation

Area of Science:

• Nephrology
• Metabolic Syndrome Research
• Cellular Biology

Background:

• Obesity and metabolic syndrome contribute to kidney disease through inflammation and declining renal function.
• Renal pathology in obesity can arise independently of hypertension and diabetes, suggesting unknown causal pathways.
• Lipid accumulation and inflammation are implicated in metabolic kidney injury.

Purpose of the Study:

• To elucidate novel pathological pathways in metabolic renal injury.
• To investigate the role of low-density lipoprotein (LDL)-induced lipotoxicity and metainflammation in kidney damage.
• To understand the mechanism linking LDL, tubular dysfunction, and the NLRP3 inflammasome.

Main Methods:

• In vitro and in vivo analyses were conducted to study metabolic overloading on tubular renal cells.
• Investigated mechanisms including intralysosomal lipid accumulation, lysosomal dysfunction, oxidative stress, and tubular dysfunction.
• Examined the interplay between the sirtuin-1/LKB1/AMPK pathway, NLRP3 inflammasome, and lipid metabolism.

Main Results:

• Demonstrated a direct lipotoxic effect of LDL on tubular renal cells, causing lipid amassing and lysosomal dysfunction.
• Showed that NLRP3 inflammasome activation, triggered by metabolic injuries, inhibits lipid breakdown via the sirtuin-1/LKB1/AMPK pathway.
• Confirmed that NLRP3 exacerbates tubular oxidative stress, mitochondrial damage, and malabsorption during overnutrition, creating a vicious cycle.

Conclusions:

• Established a causal link between LDL and tubular damage in metabolic kidney injury.
• Highlighted the critical role of the renal epithelium in lipid handling.
• Identified NLRP3 inflammasome as a central mediator of metainflammation and immunometabolism in non-immune renal cells.